H.R. 10569, Critical Infrastructure Designation. Quorum's AI analysis reads it as a net benefit — and names who gains.
H.R. 10569 · Net good
What it does
This bill directs the Department of Homeland Security's Cybersecurity and Infrastructure Security Agency (CISA) to treat biotechnology and biomanufacturing facilities as critical infrastructure requiring federal protection, even though they currently lack a designated sector-specific agency. CISA must identify stakeholders, coordinate with industry groups and information-sharing organizations, and develop a protection plan—with reporting requirements at 45 days, one year, and two years after enactment.
The analysis names biotechnology companies (cybersecurity compliance and federal threat intelligence access) — and 3 more groups — among the beneficiaries.
The trade-off
CISA gains new operational authority and staffing obligations without explicit budget appropriation language; implementation costs and resource requirements are not quantified in the bill.
Transparency scores 75%, with a medium warning level and no provisions unrelated to the bill's subject.
Who is behind it
Filed by Ro Khanna. Cosponsored by Scott Peters and Stephanie Bice.
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.